Dificid

Dificid Warnings and Precautions

• Hypersensitivity reactions: Acute reactions including difficulty breathing, rash, itching, and swelling of the mouth, throat, or face have been reported, particularly in patients with a history of macrolide allergy.
• Not for other infections: Dificid is intended only for C. difficile-associated diarrhea; using it without confirmed or strongly suspected infection increases the risk of resistant bacteria.
• Gastrointestinal effects: Nausea, vomiting, and abdominal pain are common.

How to Access Dificid in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Dificid to India?

Dificid (fidaxomicin) tablets may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified physician
• The patient's diagnostic reports confirming C. difficile-associated diarrhea
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Dificid available in India?

Dificid (fidaxomicin tablets) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Dificid is not commercially marketed in India.

However, patients in India can legally access Dificid through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Dificid received US FDA approval for the treatment of C. difficile-associated diarrhea, ensuring full transparency throughout the process.

Dificid can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Dificid

Dificid is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Dificid Across Major Cities in India

Named Patient Program supports access to Dificid for patients with C. difficile-associated diarrhea across major cities in India, coordinating documentation, sourcing, and delivery with treating physicians.

Mumbai

Patients in Mumbai can access Dificid through NPP with support from treating gastroenterologists and infectious disease specialists.

Delhi

In Delhi, NPP coordinates with hospitals and specialty clinics to facilitate timely access to Dificid.

Bangalore

Bangalore's gastroenterology and infectious disease centers work with NPP to support patients requiring Dificid.

Chennai

Patients in Chennai can access Dificid through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's gastroenterology centers support diagnosis and access coordination for Dificid through NPP.

Kolkata

NPP facilitates access to Dificid for patients in Kolkata under the guidance of treating physicians.

Pune

Patients in Pune can access Dificid through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Dificid for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Dificid through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Dificid for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Dificid through NPP with support from treating physicians.

Lucknow

NPP facilitates access to Dificid for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Dificid through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Dificid for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.